The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.25
Bid: 3.20
Ask: 3.30
Change: 0.00 (0.00%)
Spread: 0.10 (3.125%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.25
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Somero revenue short of outlook; SigmaRoc optimistic

Fri, 03rd Feb 2023 13:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Somero Enterprises Inc - Fort Myers, Florida-based laser-guided machinery concrete levelling specialist - Expects 2022 revenue of USD134.0 million, surpassing 2021's USD133.3 million. However, revenue is down from USD138.8 million guidance. This is due to "supply chain shortages in our North America market on our customers' pace of work". "The board is pleased with the strong finish to 2022 and looks forward to 2023 with confidence based on the strength of the US market, direct feedback from our customer base on activity, and the growth opportunity in Europe and Australia and from new products. To capture this opportunity, the company remains committed to adding product development, sales, and support resources; a necessary near-term investment and cost with longer-term benefit," Somero says.

----------

SigmaRoc PLC - London-based quarried materials company - Says revenue grows 19% on organic like-for-like basis to GBP525 million in 2022. On reported basis, revenue improves 93% from GBP272.0 million. Expects underlying earnings before interest, tax, depreciation and amortisation to top GBP100 million, more than doubling from GBP49.3 million. Company adds: "Trading in the early weeks of FY23 has been encouraging, with more favourable energy cost and availability conditions supporting better than expected demand in a number of the group's European industrial products segments. The group has continued to take a dynamic position on pricing through inflationary cost increases, as well as identifying opportunities to improve efficiency across its network. As such, the board remains confident in the group's ability to achieve further progress in 2023."

----------

Mycelx Technologies Corp - clean water and clean air technology company - Beats guidance as achieves 2022 revenue of USD10.0 million, up from USD8.5 million in 2021. "Mycelx has made an encouraging start to 2023, having secured a purchase order for a six-month paid trial for a PFAS remediation system for treatment of landfill leachate, a potentially large market segment for the company's PFAS remediation offering. Subject to current market conditions continuing, the company expects to meet current guidance for 2023," company adds. PFAS is a waste water removal system.

----------

Ricardo PLC - West Sussex, England-based environmental and engineering consulting - Says trading in six months to December 31 in line with board expectations. Hails "good revenue and underlying profit growth". Annual outlook unchanged. Says order intake during six-month period was 425 higher on-year at GBP290 million.

----------

accesso Technology Group PLC - Berkshire, England-based provider of software for leisure, entertainment and cultural sectors - Expects 2022 revenue of "not less" than USD139 million, beating initial forecast. Revenue in 2021 amounted to USD134.8 million, so company expects rise of around 11%. "The group's expected full year performance underscores the increased demand for its range of innovative and highly differentiated technology, along with continued commitment to revenue growth and operational excellence," company says.

----------

TPXimpact Holdings PLC - London-based IT consulting firm - Expects third-quarter revenue to fall 3.95 to GBP19.0 million from GBP19.8 million. Gross profit weakens 15% to GBP5.2 million from GBP6.1 million. Lowers annual guidance, now expects revenue of GBP80 million, down from previous outlook of GBP90 million.

----------

Vector Capital PLC - London-based commercial lending group - Expects 2022 revenue of GBP5.9 million, in line with market expectations and up 12% from GBP5.3 million in 2021. Loan book grows 15% to GBP53.4 million at year-end, from GBP46.3 million. "Despite current market conditions, the group is able in most cases to pass on interest rate increases and continues to witness strong demand from potential customers introduced by its established broker network. The company is benefitting from its diverse portfolio as it increases it weighting towards lower value loans, reflected in the average year-end loan figures referred to above," Vector Capital says.

----------

Microlise Group PLC - Nottingham, England-based transport management software firm - Adjusted earnings before interest, tax, depreciation, and amortisation "slightly ahead of market expectations" in 2022. Expects revenue growth of 5% to GBP63.2 million. However, notes "industry headwinds" and supply chain disruption. "This resulted in non-recurring revenues slightly below our forecasts. However, the company delivered record levels of OEM sales which impacted sales mix and had positive working capital effect," Microlise adds.

----------

Venture Life Group PLC - Berkshire, England-based self-care product manufacturer and distributor - Expects to post 2022 revenue of GBP44.0 million, up 34% from GBP32.8 million in 2021. Outcome would be "slightly ahead of market expectations". Adjusted earnings before interest, tax, depreciation, and amortisation to be at least in line with market expectations.

----------

Cambridge Cognition Holdings PLC - Cambridge, England-based digital health products technology developer - Says revenue for 2022 ahead of market expectations, rising 25% to GBP12.6 million from GBP10.1 million. "Order intake for the year closed at GBP13.1 million, up 8% on the previous year's order intake of GBP12.1 million, excluding GBP3.6 million of large one-off orders taken in 2021. Order growth continued across the expanded product offering, driven in part by the continued demand for virtual clinical trials," company adds.

----------

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Signs lease for laboratory space at MediCity in Nottingham. Also names Cathy Tralau-Stewart as chief scientific officer on permanent basis. Had been installed in post on interim basis. "She will also actively support the company strategically through membership of the executive team and as a board observer," ValiRx says.

----------

Goodbody Health Ltd - Somerset, England-based wellness company focusing on local community measures - Makes progress in phlebotomy services offering. Phlebotomy refers to using a needle to take blood from a vein. "The company has signed 4 phlebotomy contracts with other testing suppliers who wish to use Goodbody Clinics as a phlebotomy partner," Goodbody says.

----------

Northcoders Group PLC - Manchester-based software coding training provider - Says financial results for 2022 in line with expectations. Northcoders adds that revenue visibility for 2023 stands at GBP5.4 million an increase of 79% from this time last year. Company adds: "With demand continuing to achieve record highs, the board is confident about the group's prospects of the forthcoming year. The strong performance of the group has given the board confidence to invest additional funds to support the growth this year and beyond, and it intends to launch new growth initiatives to broaden the opportunities and appeal of the group's courses."

----------

Lift Global Ventures PLC - Financial media and energy sector focused investor - Subscribes for USD750,000 of unsecured convertible loan notes in Trans-Africa Energy Ltd. New investee is focused on developing of energy infrastructure projects located in Sub-Saharan Africa.

----------

Resolute Mining Ltd - Africa-focused gold miner - Quarterly gold output in final quarter of 2022 amounts to 91,777 ounces, from 79,816 ounces a year earlier. For 2022, output amounts to 353,069 ounces, beating 345,000 ounces guidance. For 2023, expects output of 350,000 ounces.

----------

Kendrick Resources PLC - exploration company focused on Norway, Sweden and Finland - Begins maiden diamond drill programme as Espedalen nickel project in Norway. In addition, names Martyn Churchouse as managing director. "Drilling will focus on the Stormyra ore body," Kendrick says.

----------

Clean Power Hydrogen PLC - Doncaster, England-based green hydrogen technology and manufacturing company - Strikes manufacturing agreement with New Zealand-based Fabrum Solutions Ltd. Fabrum is a cryogenic systems manufacturers for gas separation and hydrogen liquefaction. Fabrum will have right to manufacture MFE220 units in New Zealand on non-exclusive basis. "In addition, [Clean Power Hydrogen] has granted Fabrum a non-exclusive license to sell [Clean Power Hydrogen] products in New Zealand and Australia whereby [Clean Power Hydrogen] will receive a technology fee per unit," Clean Power says.

----------

Ecora Resources PLC - London-based natural resources royalty company - Hails "record" portfolio contribution of USD143.1 million in 2022, up 67% from USD85.6 million in 2021 as benefits from higher commodity prices. In fourth quarter alone, portfolio contribution falls 48% to USD17.8 million from USD34.1 million in the third quarter.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.

Read more
12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Read more
12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.

Read more
9 Feb 2024 20:24

TRADING UPDATES: ValiRx receives shareholder request for board change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Dec 2023 15:56

UK shareholder meetings calendar - next 7 days

Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
Monday 1 January 
no events scheduled 
Tuesday 2 January 
no events scheduled 
Wednesday 3 January 
Jubilee Metals Group PLCGM re equity raise
Thursday 4 January 
Rotala PLCGM re management buyout
Tintra PLCGM re cancellation, re-registering as private company
ValiRx PLCGM re operational review
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
19 Dec 2023 20:46

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Dec 2023 15:08

ValiRx enters option deal with Ambrose Healthcare

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

Read more
5 Dec 2023 11:17

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.

Read more
5 Dec 2023 10:59

AIM WINNERS & LOSERS: tinyBuild warns on revenue; ValiRx rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
10 Nov 2023 11:49

ValiRx signs deal to evaluate StingRay Bio drug candidates

(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates.

Read more
10 Nov 2023 10:32

ValiRx enters partnership with StingRay Bio

(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.

Read more
6 Oct 2023 11:35

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.